Quantum-Si

QSI · NASDAQ

$1.16+$0.07 (+6.42%)TodayMarket closed ·
Prev close $1.09

QSI analyst rating

BuyConsensus of 2 analysts over the last 12 months. 50% rate it a buy.
  • Strong buy0
  • Buy1
  • Hold1
  • Underperform0
  • Sell0

12-month price target · 4 analysts

Average $2.35 (+102.2% upside)

Low
$1.01
Now
$1.16
High
$4.20

Upgrades and downgrades

The latest rating actions, newest first

QSI analyst upgrades, downgrades and rating actions
FirmDateActionRating
HC Wainwright & Co.Sep 29, 2026MaintainsBuy
Canaccord GenuityMar 5, 2026MaintainsHold
Canaccord GenuityDec 22, 2025MaintainsHold
Canaccord GenuityOct 27, 2025MaintainsHold

The case for and against

Updated Feb 9, 2026

Bull case

Quantum-Si Inc is positioned for growth due to ongoing enhancements to its sequencing consumables and platforms, which have the potential to lead to new applications and increased market adoption rates. The introduction of the V4 Sequencing Kit is anticipated to significantly improve performance over the previous version and facilitate the analysis of complex mixtures, including antibody sequencing. These advancements may drive higher utilization levels of the company's instruments, specifically the Platinum and PlatinumPro models, thereby strengthening its market foothold in proteomics research tools.

Bear case

Quantum-Si Inc faces significant challenges that contribute to a negative outlook on its stock, primarily due to a highly competitive landscape filled with well-established players in the proteomics market. The company has experienced a history of operating losses, which are projected to persist, exacerbating concerns about its financial sustainability. Additionally, uncertainties surrounding the commercial launch of its products, reliance on third-party partnerships for manufacturing, and potential intellectual property issues further complicate its growth prospects.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.